Teva Pharmaceutical Industries Ltd (TEVA) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.093x

Based on the latest financial reports, Teva Pharmaceutical Industries Ltd (TEVA) has a cash flow conversion efficiency ratio of 0.093x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA721.91 Million ≈ $1.94 Million USD) by net assets (ILA7.76 Billion ≈ $20.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Teva Pharmaceutical Industries Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Teva Pharmaceutical Industries Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Teva Pharmaceutical Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Teva Pharmaceutical Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teva Pharmaceutical Industries Ltd ranked by their cash flow conversion efficiency. Explore Teva Pharmaceutical Industries Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jadard Technology Inc. A SHG:688252	N/A
Cinda Real Estate Co Ltd SHG:600657	-0.002x
Kidswant Children Products Co.Ltd. SHE:301078	N/A
Bangkok Life Assurance Public Company Limited BK:BLA	0.044x
Kontron AG VI:KTN	-0.006x
Navigator Holdings Ltd NYSE:NVGS	0.042x
Damora Therapeutics, Inc. NASDAQ:DMRA	-0.042x
Taiwan Fertilizer Co Ltd TW:1722	0.001x

Annual Cash Flow Conversion Efficiency for Teva Pharmaceutical Industries Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Teva Pharmaceutical Industries Ltd from 1991 to 2025. View TEVA stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA7.92 Billion ≈ $21.22 Million	ILA3.10 Billion ≈ $8.31 Million	0.392x	+79.59%
2024-12-31	ILA5.72 Billion ≈ $15.34 Million	ILA1.25 Billion ≈ $3.34 Million	0.218x	+29.50%
2023-12-31	ILA8.13 Billion ≈ $21.79 Million	ILA1.37 Billion ≈ $3.67 Million	0.168x	-7.98%
2022-12-31	ILA8.69 Billion ≈ $23.30 Million	ILA1.59 Billion ≈ $4.26 Million	0.183x	+157.78%
2021-12-31	ILA11.24 Billion ≈ $30.14 Million	ILA798.00 Million ≈ $2.14 Million	0.071x	-35.44%
2020-12-31	ILA11.06 Billion ≈ $29.65 Million	ILA1.22 Billion ≈ $3.26 Million	0.110x	+207.80%
2019-12-31	ILA15.06 Billion ≈ $40.38 Million	ILA538.00 Million ≈ $1.44 Million	0.036x	-76.94%
2018-12-31	ILA15.79 Billion ≈ $42.34 Million	ILA2.45 Billion ≈ $6.56 Million	0.155x	-17.22%
2017-12-31	ILA18.75 Billion ≈ $50.25 Million	ILA3.51 Billion ≈ $9.40 Million	0.187x	+25.30%
2016-12-31	ILA34.99 Billion ≈ $93.82 Million	ILA5.22 Billion ≈ $14.01 Million	0.149x	-19.37%
2015-12-31	ILA29.93 Billion ≈ $80.23 Million	ILA5.54 Billion ≈ $14.86 Million	0.185x	-15.64%
2014-12-31	ILA23.36 Billion ≈ $62.61 Million	ILA5.13 Billion ≈ $13.75 Million	0.220x	+53.51%
2013-12-31	ILA22.64 Billion ≈ $60.69 Million	ILA3.24 Billion ≈ $8.68 Million	0.143x	-28.48%
2012-12-31	ILA22.87 Billion ≈ $61.31 Million	ILA4.57 Billion ≈ $12.26 Million	0.200x	+8.06%
2011-12-31	ILA22.34 Billion ≈ $59.90 Million	ILA4.13 Billion ≈ $11.08 Million	0.185x	-1.57%
2010-12-31	ILA22.00 Billion ≈ $58.99 Million	ILA4.14 Billion ≈ $11.09 Million	0.188x	+7.33%
2009-12-31	ILA19.26 Billion ≈ $51.63 Million	ILA3.37 Billion ≈ $9.04 Million	0.175x	-11.32%
2008-12-31	ILA16.36 Billion ≈ $43.86 Million	ILA3.23 Billion ≈ $8.66 Million	0.197x	+49.89%
2007-12-31	ILA13.76 Billion ≈ $36.89 Million	ILA1.81 Billion ≈ $4.86 Million	0.132x	-28.44%
2006-12-31	ILA11.18 Billion ≈ $29.97 Million	ILA2.06 Billion ≈ $5.52 Million	0.184x	-18.68%
2005-12-31	ILA6.05 Billion ≈ $16.22 Million	ILA1.37 Billion ≈ $3.67 Million	0.226x	-2.09%
2004-12-31	ILA5.40 Billion ≈ $14.48 Million	ILA1.25 Billion ≈ $3.35 Million	0.231x	+21.65%
2003-12-31	ILA3.30 Billion ≈ $8.84 Million	ILA626.60 Million ≈ $1.68 Million	0.190x	-1.41%
2002-12-31	ILA1.83 Billion ≈ $4.92 Million	ILA353.70 Million ≈ $948.26K	0.193x	-2.38%
2001-12-31	ILA1.38 Billion ≈ $3.71 Million	ILA273.15 Million ≈ $732.30K	0.198x	+37.51%
2000-12-31	ILA1.15 Billion ≈ $3.09 Million	ILA165.63 Million ≈ $444.04K	0.144x	-30.58%
1999-12-31	ILA742.30 Million ≈ $1.99 Million	ILA153.61 Million ≈ $411.82K	0.207x	+94.44%
1998-12-31	ILA659.60 Million ≈ $1.77 Million	ILA70.20 Million ≈ $188.20K	0.106x	-66.31%
1997-12-31	ILA612.80 Million ≈ $1.64 Million	ILA193.60 Million ≈ $519.03K	0.316x	+2586.53%
1996-12-31	ILA535.20 Million ≈ $1.43 Million	ILA-6.80 Million ≈ $-18.23K	-0.013x	-104.91%
1995-12-31	ILA407.60 Million ≈ $1.09 Million	ILA105.40 Million ≈ $282.57K	0.259x	+131.78%
1994-12-31	ILA342.40 Million ≈ $917.96K	ILA38.20 Million ≈ $102.41K	0.112x	-20.72%
1993-12-31	ILA267.90 Million ≈ $718.23K	ILA37.70 Million ≈ $101.07K	0.141x	+11.33%
1992-12-31	ILA223.10 Million ≈ $598.12K	ILA28.20 Million ≈ $75.60K	0.126x	+154.19%
1991-12-31	ILA183.00 Million ≈ $490.62K	ILA9.10 Million ≈ $24.40K	0.050x	--

About Teva Pharmaceutical Industries Ltd

TA:TEVA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$37.65 Billion

ILA14.04 Trillion ILA

Market Cap Rank

#7879 Global

#67 in Israel

Share Price

ILA12050.00

Change (1 day)

-0.08%

52-Week Range

ILA6211.00 - ILA12060.00

All Time High

ILA25447.60